Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate

Toxicology and Applied Pharmacology

Volumn 222, Issue 2, 2007, Pages 169-179

  Moffit, Jeffrey S ^a   Koza Taylor, Petra H ^b   Holland, Ricky D ^c   Thibodeau, Michael S ^a   Beger, Richard D ^c   Lawton, Michael P ^b   Manautou, José E ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b PFIZER INC   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Acetaminophen; Clofibrate; Cystamine; Cysteamine; Hepatoprotection; Pantetheine; Pantothenic acid; Peroxisome proliferators; Vanin 1

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; CLOFIBRATE; CYSTAMINE; ENZYME; LIVER EXTRACT; MERCAPTAMINE; PARACETAMOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; RNA; UNCLASSIFIED DRUG; VANIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHIP; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYBRIDIZATION; LIVER; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; PROVOCATION TEST; RNA ISOLATION; TANDEM MASS SPECTROMETRY; UNINDEXED SEQUENCE; WILD TYPE;

ACETAMINOPHEN; ACYL-COA OXIDASE; ANIMALS; ANTICHOLESTEREMIC AGENTS; CELL ADHESION MOLECULES; CLOFIBRATE; CLUSTER ANALYSIS; CYSTAMINE; CYSTEAMINE; ENOYL-COA HYDRATASE; GENE EXPRESSION PROFILING; LIVER; LIVER DISEASES; MALATE DEHYDROGENASE; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANTETHEINE; PANTOTHENIC ACID; PEROXISOME PROLIFERATORS; PPAR ALPHA; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS; RODENTIA;

EID: 34447632203     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.04.008     Document Type: Article

References (47)

1. Adamson E.D., and Mercola D. Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumour Biol. 23 (2002) 93-102
2. Anderson S.P., Howroyd P., Liu J., Qian X., Bahnemann R., Swanson C., Kwak M.K., Kensler T.W., and Corton J.C. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J. Biol. Chem. 279 (2004) 52390-52398
3. Bartolone J.B., Beierschmitt W.P., Birge R.B., Hart S.G., Wyand S., Cohen S.D., and Khairallah E.A. Selective acetaminophen metabolite binding to hepatic and extrahepatic proteins: an in vivo and in vitro analysis. Toxicol. Appl. Pharmacol. 99 (1989) 240-249
4. Berruyer C., Martin F.M., Castellano R., Macone A., Malergue F., Garrido-Urbani S., Millet V., Imbert J., Dupre S., Pitari G., Naquet P., and Galland F. Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol. Cell. Biol. 24 (2004) 7214-7224
5. Brucer M., and Mewissen D.J. Late effects of gamma radiation on mice protected with cysteamine or cystamine. Nature 179 (1957) 201-202
6. Castro J.A., De Ferreyra E.C., De Castro C.R., Diaz Gomez M.I., D'Acosta N., and De Fenos O.M. Studies on the mechanism of cystamine prevention of several liver structural and biochemical alterations caused by carbon tetrachloride. Toxicol. Appl. Pharmacol. 24 (1973) 1-19
7. Chen C., Hennig G.E., Whiteley H.E., Corton J.C., and Manautou J.E. Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure. Toxicol. Sci. 57 (2000) 338-344
8. Chen C., Hennig G.E., Whiteley H.E., and Manautou J.E. Protection against acetaminophen hepatotoxicity by clofibrate pretreatment: role of catalase induction. J. Biochem. Mol. Toxicol. 16 (2002) 227-234
9. Dean M.M., Minchinton R.M., Heatley S., and Eisen D.P. Mannose binding lectin acute phase activity in patients with severe infection. J. Clin. Immunol. 25 (2005) 346-352
10. Faig M., Bianchet M., Talalay P., Chen C., Winski S., Ross D., and Amzel L. Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release. Proc. Natl. Acad. Sci. 97 (2000) 3177-3182
11. Gerson R.J., Casini A., Gilfor D., Serroni A., and Farber J.L. Oxygen-mediated cell injury in the killing of cultured hepatocytes by acetaminophen. Biochem. Biophys. Res. Commun. 126 (1985) 1129-1137
12. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003) 895-899
13. James L.P., Simpson P.M., Farrar H.C., Kearns G.L., Wasserman G.S., Blumer J.L., Reed M.D., Sullivan J.E., and Hinson J.A. Cytokines and toxicity in acetaminophen overdose. J. Clin. Pharmacol. 45 (2005) 1165-1171
14. Jollow D.J., Mitchell J.R., Potter W.Z., Davis D.C., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis: II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187 (1973) 195-202
15. Landin J.S., Cohen S.D., and Khairallah E.A. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. Toxicol. Appl. Pharmacol. 141 (1996) 299-307
16. Liao Y., Shikapwashya O.N., Shteyer E., Dieckgraefe B.K., Hruz P.W., and Rudnick D.A. Delayed hepatocellular mitotic progression and impaired liver regeneration in early growth response-1-deficient mice. J. Biol. Chem. 279 (2004) 43107-43116
17. Liu Z.X., Govindarajan S., and Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127 (2004) 1760-1774
18. MacDonald J.R., Gandolfi A.J., and Sipes I.G. Cystamine treatment of chemically induced liver injury. Dev. Toxicol. Environ. Sci. 11 (1983) 463-466
19. Manautou J.E., Hoivik D.J., Tveit A., Hart S.G., Khairallah E.A., and Cohen S.D. Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity. Toxicol. Appl. Pharmacol. 129 (1994) 252-263
20. Manautou J.E., Tveit A., Hoivik D.J., Khairallah E.A., and Cohen S.D. Protection by clofibrate against acetaminophen hepatotoxicity in male CD-1 mice is associated with an early increase in biliary concentration of acetaminophen-glutathione adducts. Toxicol. Appl. Pharmacol. 140 (1996) 30-38
21. Manautou J.E., Silva V.M., Hennig G.E., and Whiteley H.E. Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice. Toxicology 127 (1998) 1-10
22. Martin F., Penet M.F., Malergue F., Lepidi H., Dessein A., Galland F., de Reggi M., Naquet P., and Gharib B. Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores. J. Clin. Invest. 113 (2004) 591-597
23. Mehendale H.M. PPAR-alpha: a key to the mechanism of hepatoprotection by clofibrate. Toxicol. Sci. 57 (2000) 187-190
24. Mehendale H.M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 33 (2005) 41-51
25. Miller M.G., and Jollow D.J. Acetaminophen hepatotoxicity: studies on the mechanism of cysteamine protection. Toxicol. Appl. Pharmacol. 83 (1986) 115-125
26. Miners J.O., Drew R., and Birkett D.J. Mechanism of action of paracetamol protective agents in mice in vivo. Biochem. Pharmacol. 33 (1984) 2995-3000
27. Mitchell J.R., Jollow D.J., Potter W.Z., Davis D.C., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis: I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187 (1973) 185-194
28. Mitchell J.R., Jollow D.J., Potter W.Z., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis: IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187 (1973) 211-217
29. Miura Y., Shimazu R., Miyake K., Akashi S., Ogata H., Yamashita Y., Narisawa Y., and Kimoto M. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood 92 (1998) 2815-2822
30. Nguyen K.A., Carbone J.M., Silva V.M., Chen C., Hennig G.E., Whiteley H.E., and Manautou J.E. The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice. J. Toxicol. Environ. Health, Part A 58 (1999) 171-186
31. Nicholls-Grzemski F.A., Calder I.C., and Priestly B.G. Peroxisome proliferators protect against paracetamol hepatotoxicity in mice. Biochem. Pharmacol. 43 (1992) 1395-1396
32. Nicholls-Grzemski F.A., Belling G.B., Priestly B.G., Calder I.C., and Burcham P.C. Clofibrate pretreatment in mice confers resistance against hepatic lipid peroxidation. J. Biochem. Mol. Toxicol. 14 (2000) 335-345
33. Nicholls-Grzemski F.A., Calder I.C., Priestly B.G., and Burcham P.C. Clofibrate-induced in vitro hepatoprotection against acetaminophen is not due to altered glutathione homeostasis. Toxicol. Sci. 56 (2000) 220-228
34. Olinescu R., Nita S., and Pascu N. Biochemical mechanisms involved in the hepatotoxicity of some drugs. Med. Interne 20 (1982) 59-65
35. Olinescu R., Nita S., and Pascu N. Biomechanical mechanisms involved in the hepatotoxicity of some drugs. Med. Interne 20 (1982) 59-65
36. Pitari G., Malergue F., Martin F., Philippe J.M., Massucci M.T., Chabret C., Maras B., Dupre S., Naquet P., and Galland F. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett. 483 (2000) 149-154
37. Prescott L.F., Newton R.W., Swainson C.P., Wright N., Forrest A.R., and Matthew H. Successful treatment of severe paracetamol overdosage with cysteamine. Lancet 1 (1974) 588-592
38. Ricci G., Nardini M., Chiaraluce R., Dupre S., and Cavallini D. Interaction of pantetheinase with sulfhydryl reagents and disulfides. Biochim. Biophys. Acta 870 (1986) 82-91
39. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
40. Siew C., Deitrich R.A., and Erwin V.G. Localization and characteristics of rat liver mitochondrial aldehyde dehydrogenases. Arch. Biochem. Biophys. 176 (1976) 638-649
41. Stroo W.E., Olson R.D., and Boerth R.C. Efficacy of sulfhydryl compounds as inhibitors of iron-dependent doxorubicin-enhanced lipid peroxidation. Res. Commun. Chem. Pathol. Pharmacol. 48 (1985) 291-303
42. Tredger J.M., Smith H.M., Davis M., and Williams R. Effects of sulphur-containing compounds on paracetamol activation and covalent binding in a mouse hepatic microsomal system. Toxicol. Lett. 5 (1980) 339-344
43. Wendel A., Feuerstein S., and Konz K.H. Acute paracetamol intoxication of starved mice leads to lipid peroxidation in vivo. Biochem. Pharmacol. 28 (1979) 2051-2055
44. Wong J.S., and Gill S.S. Gene expression changes induced in mouse liver by di(2-ethylhexyl) phthalate. Toxicol. Appl. Pharmacol. 185 (2002) 180-196
45. Xu Y., Cook T.J., and Knipp G.T. Effects of di-(2-ethylhexyl)-phthalate (DEHP) and its metabolites on fatty acid homeostasis regulating proteins in rat placental HRP-1 trophoblast cells. Toxicol. Sci. 84 (2005) 287-300
46. Yamazaki K., Kuromitsu J., and Tanaka I. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor alpha agonists. Biochem. Biophys. Res. Commun. 290 (2002) 1114-1122
47. Yokosuka T., Sakata-Sogawa K., Kobayashi W., Hiroshima M., Hashimoto-Tane A., Tokunaga M., Dustin M.L., and Saito T. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat. Immunol. (2005)